99久久国产热无码精品-天摸天天操天天操天天日-色777狠狠综合秋免鲁丝-国产精品一区二区三区国产

熱門搜索: 硫酸角質(zhì)素(KS)ELISA試劑盒(種屬:魚) 白介素6(IL6)ELISA試劑盒(種屬:魚) 魚白介素10(IL10)ELISA試劑盒發(fā)貨及時(shí) 斑馬魚白介素12BELISA試劑盒發(fā)貨及時(shí) 兔載脂蛋白B(apo-B)ELISA試劑盒發(fā)貨及時(shí) 兔孕酮(PROG)ELISA試劑盒發(fā)貨及時(shí) 兔羥脯氨酸(Hyp)ELISA試劑盒發(fā)貨及時(shí) 兔抗酒石酸酸性磷酸酶ELISA試劑盒發(fā)貨及時(shí) 兔晶體蛋白α(Cryα)ELISA試劑盒發(fā)貨及時(shí) 兔結(jié)締組織生長(zhǎng)因子ELISA試劑盒發(fā)貨及時(shí) 兔基質(zhì)金屬蛋白酶9ELISA試劑盒發(fā)貨及時(shí) 兔肺表面活性物質(zhì)相ELISA試劑盒發(fā)貨及時(shí) CD206分子ELISA試劑盒(種屬:小鼠) CC趨化因子受體6ELISA試劑盒(種屬:小鼠) 阻抑素(PHB)ELISA試劑盒(種屬:大鼠) 中性內(nèi)肽酶;腦啡ELISA試劑盒(種屬:大鼠)

技術(shù)文章/ Technical Articles

您的位置:首頁(yè)  /  技術(shù)文章  /  引用大鼠ELISA科研檢測(cè)試劑盒的文獻(xiàn)

引用大鼠ELISA科研檢測(cè)試劑盒的文獻(xiàn)

更新時(shí)間:2023-09-19      瀏覽次數(shù):1402

引用大鼠ELISA科研檢測(cè)試劑盒的文獻(xiàn)


文獻(xiàn)收集:

Epimedium Aqueous Extract Ameliorates Cerebral Ischemia/Reperfusion Injury through Inhibiting ROS/NLRP3- Mediated Pyroptosis

引用試劑盒:

種屬:大鼠

IL-1β (RJ15465), IL-18 (RJ15463),TNF-α (RJ16622), IL-6 (RJ15478), IL-10 (RJ15453),iNOS(RJ16565) , MDA (RJ15503), ROS(RJ15780) ,CAT(RJ15737),SOD(RJ16691) ,GSHPx(RJ25745) , LDH (RJ16172)

 

638272614877654132225.jpg

IF:7.675


Abstract: Cerebral ischemia/reperfusion causes exacerbated neuronal damage involving excessive neuroinflammation and oxidative stress. ROS is considered a signal molecule to activate NLRP3; thus, the ROS/NLRP3/pyroptosis axis plays a vital role in the pathogenesis of cerebral ischemia/reperfusion injury (CIRI). Therefore, targeting the inhibition of the ROS/NLRP3/pyroptosis axis may be a promising therapeutic tactic for CIRI. Epimedium (EP) contains many active ingredients (ICA, ICS II, and ICT), which have a wide range of pharmacological activities. However, whether EP can protect against CIRI remains unknown. Thus, in this study, we designed to investigate the effect and possible underlying mechanism of EP on CIRI. The results showed that treatment with EP dramatically mitigated brain damage in rats following CIRI, which was achieved by suppressing mitochondrial oxidative stress and neuroinflammation. Furthermore, we identified the ROS/NLRP3/pyroptosis axis as a vital process and NLRP3 as a vital target in EP-mediated protection. Most interestingly, the main compounds of EP directly bonded with NLRP3, as reflected by molecular docking, which indicated that NLRP3 might be a promising therapeutic target for EP-elicited cerebral protection. In conclusion, our findings illustrate that ICS II protects against neuron loss and neuroinflammation after CIRI by inhibiting ROS/NLRP3-mediated pyroptosis.


image.png









微信掃一掃

郵箱:2450868877@qq.com

傳真:86-區(qū)號(hào)-傳真號(hào)碼

地址:上海市楊浦區(qū)鐵嶺路32號(hào)1519-10室

Copyright © 2025 上海仁捷生物科技有限公司版權(quán)所有   備案號(hào):滬ICP備16052159號(hào)-1   總訪問(wèn)量:319936   技術(shù)支持:化工儀器網(wǎng)

TEL:17302193538

掃碼加微信
贵阳市| 察隅县| 石景山区| 香格里拉县| 抚松县| 绥化市| 长泰县| 镶黄旗| 江华| 湟中县| 武汉市| 罗城| 弋阳县| 临夏市| 东辽县| 上栗县| 平武县| 同仁县| 乌海市| 丽水市| 高雄市| 裕民县| 河西区| 家居| 班玛县| 斗六市| 山西省| 库尔勒市| 旬阳县| 铜梁县| 长乐市| 章丘市| 和硕县| 泸水县| 卫辉市| 内丘县| 武冈市| 饶河县| 页游| 宜兴市| 渭源县|